ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Activity score"

  • Abstract Number: 2475 • 2013 ACR/ARHP Annual Meeting

    Relationship Between Extra-Articular Manifestations and Disease Activity In Patients Diagnosed With New-Onset Spondyloarthropathy In a Cohort In Spain

    César Antonio Egües Dubuc1, Maria Martin Martinez2, Joaquin Belzunegui Otano1, Miren Uriarte Ecenarro1, Juan Mulero3, Eugenio de Miguel4, Santiago Muñoz5, Pedro Zarco6, Eduardo Collantes7, Sabina Perez Vicente2 and Milena Gobbo2, 1Rheumatology, Donostia University Hospital, San Sebastián, Spain, 2Research Unit, Spanish Society of Rheumatology., Madrid, Spain, 3Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda (Madrid), Spain, 4Rheumatology, University Hospital La Paz - IdiPaz, Madrid, Spain, 5Rheumatology, Hospital Infanta Sofia, Madrid, Spain, 6Rheumatology Service, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, 7Rheumatology, Hospital Reina Sofia, Cordoba, Spain

    Background/Purpose : The Spondyloarthropathy (SpA) that affect in many aspects of life of the patients, either for their musculoskeletal or extra-articular manifestations (EAM). EAM vary…
  • Abstract Number: 2395 • 2013 ACR/ARHP Annual Meeting

    Plasma Short-Talin Is a New Rheumatoid Arthritis Monitoring Biomarker Independent Of The Inflammatory Markers

    Kensei Tsuzaka, Masako Takao and Jiro Nishida, Dept of Internal Medicine, Ichikawa General Hospital,TDC, Ichikawa, Chiba, Japan

    Methods: ). Sixteen (31.4 %) of these 51 patients were untreated, and 18 patients (35.3%) were treated with biologics DMARD at the time of collecting…
  • Abstract Number: 2289 • 2013 ACR/ARHP Annual Meeting

    Correlation Of Anti-Citrullinated Protein and Anti-Carp Antibodies With Disease Duration and Activity In Rheumatoid Arthritis

    Michael Mahler1, Gabriella Lakos1, Tyler Webb1, Alvin Yee1, Leendert A. Trouw2 and Pier-Luigi Meroni3, 1Research, INOVA Diagnostics, San Diego, CA, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Int Medicine, University of Milan, Milano, Italy

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) and rheumatoid factor (RF) are important serological markers in the diagnosis of rheumatoid arthritis (RA) and are part of the…
  • Abstract Number: 2248 • 2013 ACR/ARHP Annual Meeting

    Difference Between The Two Versions Of Disease Activity Score Based On C-Reactive Protein and Erythrocyte Sedimentation Rate

    Pinar Cetin1, Dilek Solmaz1, Hacer Gulluoglu2, Ismail Sari1, Merih Birlik1, Servet Akar1, Fatos Onen1 and Nurullah Akkoc1, 1Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey, 2Internal Medicine, Dokuz Eylul University School of Medicine, Ýzmir, Turkey

    Background/Purpose: In some countries reimbursement criteria require a DAS28 score of >5.1 for initiating anti-TNF therapy in patients with rheumatoid arthritis. DAS28 score can be…
  • Abstract Number: 1669 • 2013 ACR/ARHP Annual Meeting

    The Birmingham Vasculitis Activity Score As a Measure Of Disease Activity In Patients With Giant Cell Arteritis

    Tanaz A. Kermani1, David Cuthbertson2, Simon Carette3, Gary S. Hoffman4, Nader A. Khalidi5, Curry L. Koening6, Carol A. Langford7, Kathleen McKinnon-Maksimowicz8, Carol McAlear9, Paul A. Monach10, Philip Seo11, Kenneth J. Warrington12, Steven R. Ytterberg13, Peter A Merkel14 and Eric L. Matteson15, 1Rheumatology, University of California Los Angeles, Los Angeles, CA, 2Department of Biostatistics, University of South Florida, Tampa, FL, 3Division of Rheumatology, University of Toronto, Toronto, ON, Canada, 4Center for Vasculitis Care and Research, Cleveland Clinic Foundation, Cleveland, OH, 5Internal Medicine/Rheumatology, McMaster University, Hamilton, ON, Canada, 6Internal Medicine, Salt Lake City Veterans Administration, Salt Lake City, UT, 7Center for Vasculitis Care and Research, Cleveland Clinic, Cleveland, OH, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 9University of Pennsylvania, Philadelphia, PA, 10Rheumatology, Boston University, Boston, MA, 11Rheumatology Division, Johns Hopkins Vasculitis Center, Johns Hopkins University, Baltimore, MD, 12Division of Rheumatology, Mayo Clinic, Rochester, MN, 13Rheumatology Division, Mayo Clinic, Rochester, MN, 14Division of Rheumatology, University of Pennsylvania and VA Medical Center, Philadelphia, PA, 15Rheumatology, Mayo Clinic, Rochester, MN

       Background/Purpose: To evaluate the performance of the Birmingham Vasculitis Activity Score (BVAS), a validated tool for assessment of vasculitis disease activity, in a cohort…
  • Abstract Number: 1530 • 2013 ACR/ARHP Annual Meeting

    Vitamin D Deficiency Is Associated With a More Active and Severe Disease In Early Axial Spondyloarthritis: Data From The DESIR Cohort

    Ihsane Hmamouchi1, Simon Paternotte2, Didier Borderie3 and Maxime Dougados4, 1Biostatistics, Epidemiology LBRCE, Mohamed V Souissi University, Rabat, Morocco, 2Rheumatology Department, Paris- Descartes University, Cochin hospital, Paris, France, 3Laboratoire de Biochimie, Hopital Cochin, Paris Descartes University, Pris, France, 4Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France

    Background/Purpose: Objectives a) to describe the vitamin D status b) to assess the relationship between vitamin D status and disease activity/severity and c) to estimate…
  • Abstract Number: 1531 • 2013 ACR/ARHP Annual Meeting

    Agreement Between Disease Activity States and Improvement Scores As Defined by Bath Ankylosing Spondylitis Disease Activity Index and Ankylosing Spondylitis Disease Activity Score Cut-Off Values

    Dilek Solmaz, Pinar Cetin, Ismail Sari, Merih Birlik, Servet Akar, Fatos Onen and Nurullah Akkoc, Rheumatology, Dokuz Eylul University School of Medicine, Izmir, Turkey

    Background/Purpose: BASDAI has been extensively used to assess disease activity in ankylosing spondylitis (AS) BASDAI score ≥4 represent high disease activity and has been suggested as…
  • Abstract Number: 1311 • 2013 ACR/ARHP Annual Meeting

    Aiming Simple Disease Activity Score Remission At One Year Leads To Better 3-Year Radiographic and Functional Outcomes Than aiming low Disease activity in Early Rheumatoid Arthritis Patients Treated In Routine Practice. Data From Espoir Cohort

    Adeline Ruyssen-Witrand1, Gregory Guernec2, Delphine Nigon3, Gabriel Tobon4, Bénédicte Jamard5, Anne-Christine Rat6, Olivier Vittecoq7, Alain G. Cantagrel8 and Arnaud L. Constantin1, 1Rheumatology, Purpan University Hospital, Toulouse, France, 2UMR 1027, Inserm, Toulouse, France, 3Rheumatology, CHU Purpan - Hôpital Pierre-Paul Riquet, Toulouse, France, 4Unit of immunology, Brest, France, 5Toulouse University Hospital, Toulouse, France, 6Université de Lorraine, Nancy, F-54000, France; Inserm, CIC-EC CIE6, Nancy, F-54000, France; CHU de Nancy, Clinical Epidemiology and Evaluation Department, Nancy, F-54000, France; CHU de Nancy, Rheumatology department, Nancy, France, 7Rheumatology, Rouen University Hospital & Inserm905, University of Rouen, Rouen Cedex, France, 8Centre Hospitalier Universitaire de Toulouse, Toulouse, France

    Background/Purpose: The ultimate goal of Disease Modifying Anti-Rheumatic Drugs (DMARDs) treatment in early rheumatoid arthritis (RA) is to achieve remission in order to prevent structural…
  • Abstract Number: 1234 • 2012 ACR/ARHP Annual Meeting

    Barriers, Benefits and Preferences for Exercise in RA Patients: A Cross Sectional Study

    Yves Henchoz1, Pascal Zufferey2 and Alexander So3, 1Département de chiropratique, Université du Québec à Trois-Rivières, Trois-Rivières, QC, Canada, 2Service of Rheumatology, Department of Musculoskeletal Medicine, Lausanne University Hospital, Lausanne, Switzerland, 3Rheumatology, CHUV, Univ of Lausanne, Lausanne, Switzerland

    Background/Purpose: Physical exercise is safe and effective as an adjunctive nonpharmacological treatment modality in the management of rheumatoid arthritis (RA). It is well established that…
  • Abstract Number: 124 • 2012 ACR/ARHP Annual Meeting

    Reliability of an Ultrasound Scoring Measure for Juvenile Localized Scleroderma (jLS)

    Suzanne C. Li1, Melissa S. Liebling2, Andrea S. Doria3, Molly Dempsey-Robertson4, Carsten Hamer5, Sven Opitz5, Faridali Ramji6, Stephanie Edgerton6, Jose Jarrin3, Tanicka Kornyat2, Michael Malone6, Arun Mohanta3, Shuzhen Zhang4 and Knut M. Wittkowski7, 1Pediatrics, Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, 2Radiology, Hackensack University Medical Center, Hackensack, NJ, 3Diagnostic Imaging, Hospital for Sick Children, Toronto, ON, Canada, 4Radiology, Texas Scottish Rite Hospital, Dallas, TX, 5Radiology, Schon Klinik Hamburg Eilbek, Hamburg, Germany, 6Radiology, University of OK Health Science Center, Okc, OK, 7Center for Clinical and Translational Science, Rockefeller University, New York, NY

    Background/Purpose: Although ultrasound (US) shows great potential for aiding assessment of LS disease activity, its use has been limited because both image acquisition and interpretation…
  • Abstract Number: 1158 • 2012 ACR/ARHP Annual Meeting

    Development of Cut-off Values for High Disease Activity in Juvenile Idiopathic Arthritis Based On the Juvenile Arthritis Disease Activity Score

    Alessandro Consolaro1, Stefano Lanni1, Sara Verazza1, Maria C. Gallo1, Marta Bertamino1, Giulia C. Varnier1, Serena Calandra2, Nicolino Ruperto3, Alberto Martini4 and Angelo Ravelli5, 1Pediatria II, Istituto Giannina Gaslini, Genova, Italy, 2University of Genova, Genova, Italy, 3Paediatric Rheumatology International Trials Organisation [PRINTO], Genova, Italy, 4Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH, 5Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy

    Background/Purpose: In the last decade, there have been major advances in the management of juvenile idiopathic arthritis (JIA), including the shift towards early aggressive interventions…
  • Abstract Number: 76 • 2012 ACR/ARHP Annual Meeting

    The Difference in Performance of DAS28 and RADAI During Pregnancy Might Explain Discrepancies Between Older and More Recent Studies On the Impact of Pregnancy On Rheumatoid Arthritis

    Jan Naterop1, Johanna M.W. Hazes2 and Radboud J.E.M. Dolhain3, 1Rheumatology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands, Rotterdam, Netherlands, 2Rheumatology, Erasmus University Medical Center, Rotterdam, Netherlands, 3Rheumatology, Erasmus Medical Center, Rotterdam, Netherlands

    Background/Purpose: Pregnancy is the only condition in which Rheumatoid Arthritis (RA) shows spontaneous remission. Both older and more recent studies showed improvement of disease activity,…
  • Abstract Number: 1091 • 2012 ACR/ARHP Annual Meeting

    Trends in Patient Physical Activity Before and After Primary Total Hip Arthroplasty

    Anne Lübbeke1, Dorith Zimmermann2, Constantinos Roussos1, Alexis Bonvin1, Robin Peter1 and Pierre Hoffmeyer1, 1Orthopaedic Surgery, Geneva University Hospitals, Geneva, Switzerland, 2Geneva University Hospitals, Geneva, Switzerland

    Background/Purpose: Total hip arthroplasties (THA) are performed to reduce pain and enhance patients’ function and physical activity (PA) level. PA is also recognized as the…
  • Abstract Number: 77 • 2012 ACR/ARHP Annual Meeting

    Comorbid Conditions Do Not Explain Divergent Patient Assessments of Disease Activity and Global Health in Patients with Rheumatoid Arthritis

    Dörte Huscher1, Katja Thiele2, Sascha Bischoff2, Ulrich von Hinüber3, Guido Hoese4, Kirsten Karberg5, Wolfgang Ochs6 and Angela Zink7, 1German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany, 2German Rheumatism Research Centre, Berlin, Germany, 3Rheumatologist in Private Practice, Hildesheim, Germany, 4Rheumatologist in Private Practice, Stadthagen, Germany, 5Rheumatologist in Private Practice, Berlin, Germany, 6Rheumatologist in Private Practice, Bayreuth, Germany, 7Epidemiology Unit, German Rheumatism Research Centre and Charité University Medicine, Berlin, Germany

    Background/Purpose: In the discussion of the 2010 ACR/EULAR remission criteria  the issue has been raised to what extent patients are able to distinguish rheumatoid arthritis…
  • Abstract Number: 1044 • 2012 ACR/ARHP Annual Meeting

    Ultrasound Scores of Enthesitis and Dactylitis Do Not Correlate with Corresponding Clinical Findings in Psoriasis Arthritis

    Rusmir Husic1, Josef Hermann1, Judith Gretler2, Winfried B. Graninger3 and Christian Dejaco4, 1Rheumatology, Medical University Graz, Graz, Austria, 2Med Univ Klinik Graz, Auenbruggerplatz 15, Graz, Austria, 3Internal medicine/Rheumatology and Immunology, Medical University Graz, Graz, Austria, 4Rheumatology, Southend University Hospital, Westcliff-on-Sea, United Kingdom

    Background/Purpose: To compare sonography verified inflammation of entheses, tendons and joints with corresponding clinical findings in psoriasis arthritis (PsA) patients. Methods: Prospective study of 70 consecutive…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology